PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
59.45%
Similar revenue growth to CRON.TO's 60.92%. Walter Schloss would investigate if similar growth reflects similar quality.
2402.78%
Cost growth above 1.5x CRON.TO's 163.80%. Michael Burry would check for structural cost disadvantages.
-53.84%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-73.33%
Both companies show margin pressure. Martin Whitman would check industry conditions.
128.48%
R&D growth 1.25-1.5x CRON.TO's 100.93%. Martin Whitman would scrutinize investment rationale.
-2.99%
G&A reduction while CRON.TO shows 68.84% growth. Joel Greenblatt would examine efficiency advantage.
71.99%
Marketing expense growth less than half of CRON.TO's 263.29%. David Dodd would verify if efficiency advantage is sustainable.
770.17%
Other expenses growth above 1.5x CRON.TO's 46.07%. Michael Burry would check for concerning trends.
11.13%
Operating expenses growth less than half of CRON.TO's 92.69%. David Dodd would verify sustainability.
80.79%
Total costs growth less than half of CRON.TO's 342.57%. David Dodd would verify sustainability.
68.97%
Interest expense growth while CRON.TO reduces costs. John Neff would investigate differences.
-15.84%
D&A reduction while CRON.TO shows 60.06% growth. Joel Greenblatt would examine efficiency.
117.98%
EBITDA growth while CRON.TO declines. John Neff would investigate advantages.
726.73%
EBITDA margin growth while CRON.TO declines. John Neff would investigate advantages.
-103.69%
Both companies show declining income. Martin Whitman would check industry conditions.
-27.74%
Both companies show margin pressure. Martin Whitman would check industry conditions.
91.61%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
143.88%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
52.95%
Pre-tax margin growth while CRON.TO declines. John Neff would investigate advantages.
95.09%
Tax expense growth while CRON.TO reduces burden. John Neff would investigate differences.
153.01%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
58.67%
Net margin growth while CRON.TO declines. John Neff would investigate advantages.
141.84%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
141.84%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
8.51%
Share count reduction exceeding 1.5x CRON.TO's 52.85%. David Dodd would verify capital allocation.
8.22%
Diluted share reduction exceeding 1.5x CRON.TO's 38.21%. David Dodd would verify capital allocation.